Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 148.81 billion. The enterprise value is 167.62 billion.

Market Cap	148.81B
Enterprise Value	167.62B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Jun 16, 2025

Share Statistics

Current Share Class	2.51B
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 11.03 and the forward PE ratio is 9.01.

PE Ratio	11.03
Forward PE	9.01
PS Ratio	3.01
PB Ratio	3.97
P/TBV Ratio	17.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.85, with an EV/FCF ratio of 12.71.

EV / Earnings	12.42
EV / Sales	3.58
EV / EBITDA	7.85
EV / EBIT	9.38
EV / FCF	12.71

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	668,581
Profits Per Employee	182,348
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

In the past 12 months, Merck & Co. has paid 2.10 billion in taxes.

Income Tax	2.10B
Effective Tax Rate	13.48%

Stock Price Statistics

The stock price has decreased by -36.56% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-36.56%
50-Day Moving Average	79.26
200-Day Moving Average	93.11
Relative Strength Index (RSI)	54.58
Average Volume (20 Days)	13,449

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.13

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 49.47 billion and earned 13.49 billion in profits. Earnings per share was 5.32.

Revenue	49.47B
Gross Profit	38.13B
Operating Income	18.89B
Pretax Income	15.61B
Net Income	13.49B
EBITDA	22.29B
EBIT	18.89B
Earnings Per Share (EPS)	5.32

Full Income Statement

Balance Sheet

The company has 7.14 billion in cash and 26.97 billion in debt, giving a net cash position of -19.83 billion.

Cash & Cash Equivalents	7.14B
Total Debt	26.97B
Net Cash	-19.83B
Net Cash Per Share	n/a
Equity (Book Value)	37.46B
Book Value Per Share	14.87
Working Capital	7.99B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.16 billion and capital expenditures -2.97 billion, giving a free cash flow of 13.19 billion.

Operating Cash Flow	16.16B
Capital Expenditures	-2.97B
Free Cash Flow	13.19B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

This stock pays an annual dividend of 2.44, which amounts to a dividend yield of 3.02%.

Dividend Per Share	2.44
Dividend Yield	3.02%
Dividend Growth (YoY)	1.63%
Years of Dividend Growth	3
Payout Ratio	45.54%
Buyback Yield	0.30%
Shareholder Yield	3.31%
Earnings Yield	9.07%
FCF Yield	8.86%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score	4.7
Piotroski F-Score	7